Menu
Tip of the Day
COURAGE Quality-of-Life Analysis: Slim Early Gains With PCI Soon Disappear
August 14, 2008 -- The results of their quality-of-life (QoL) analysis from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial [1] are consistent with the message from its primary outcomes [2] and other secondary results, conclude researchers. That message: Percutaneous coronary intervention (PCI) can often be deferred in patients with stable coronary artery disease (CAD) and significant coronary lesions without adding risk while optimal medical therapy (OMT) is given a chance to work, and it can be considered later if the patient still develops significant symptoms, according to the group. ...more
EP Consult
We provide our colleagues some consults related to heart problems.
Please complete this form and attach your files then submit it.
We will contact you via your Email.
Note: Please fill all fields marked with (*)
You can attach up to 3 image file (for example, an ECG file) to this request. To do so, click on the "Browse" button and select your file on your computer. After finishing the form, click on "Submit".